Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New protein farnesyltransferase inhibitors described by Schering-Plough

April 30, 2002

Genta and Aventis collaborate on Genasense development and commercialization

April 30, 2002

LY-402913, a selective MRP1 inhibitor with in vivo resistance-modulating activity

April 30, 2002

Combination of antimetabolite and thymidine phosphorylase inhibitor in clinical development at Taiho

April 30, 2002

Drug used for xerostomia may help prevent lung cancer

April 30, 2002

Lexicon Genetics discovers new oncogene for development of anticancer drugs

April 30, 2002

Marketing application filed in E.U. for Axcan's photodynamic therapy

April 30, 2002

Pharmacyclics claims metallotexaphyrins and use in diagnosis and therapy

April 29, 2002

Faslodex approved in U.S. for tamoxifen-resistant breast cancer

April 29, 2002

EMEA accepts Thalomid MAA for review

April 29, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...